Biofeedback for Fecal Incontinence

Completed · Not applicable

Conditions studied: Fecal Incontinence

In brief

Fecal incontinence affects 2% of adults in the United States. Biofeedback has been recommended for the treatment of fecal incontinence because uncontrolled studies over the past 25 years suggest that these treatments are as effective as medical or surgical management and involve no risk. However, placebo-controlled trials are still lacking. The aims of this study are: (1) to compare biofeedback to alternative therapies for which patients have a similar expectation of benefit; (2) to identify which patients are most likely to benefit; and (3) to assess the impact of treatment on quality of life.

Key facts

Study ID

NCT00124904

Run by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

People needed

165

Starts

1999-09-01

Expected to finish

2006-12-01

Last updated by the study team

2010-01-13

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males or females age 16 or above who have an average of one or more episodes of fecal incontinence per week

You may not qualify if…

• Previous biofeedback treatment

Where it is running

• University of North Carolina Department of Medicine — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.